Germacrone alleviates okadaic acid-induced neurotoxicity in PC12 cells via M1 muscarinic receptor-mediated Galphaq (Gq)/phospholipase C beta (PLCβ)/ protein kinase C (PKC) signaling

References

• Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. Handb Clin Neurol. 2019;167:231–255.
   PubMedGoogle Scholar
• Garre-Olmo J. [Epidemiology of Alzheimer’s disease and other dementias]. Rev Neurol. 2018;66(11):377–386.
   PubMed Web of Science ®Google Scholar
• Weller J, Budson A, Bollag L. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res. 2018;7:7.
   PubMedGoogle Scholar
• Breijyeh Z, and Karaman R. Comprehensive Review on Alzheimer’s Disease: causes and Treatment. Molecules. 2020;25:5789.
   PubMed Web of Science ®Google Scholar
• Briggs R, Kennelly SP, O’Neill D. Drug treatments in Alzheimer’s disease. Clin Med (Lond). 2016;16(3):247–253.
   PubMed Web of Science ®Google Scholar
• Serý O, Povová J, Míšek I, et al. Molecular mechanisms of neuropathological changes in Alzheimer’s disease: a review. Folia Neuropathol. 2013;51:1–9.
   PubMed Web of Science ®Google Scholar
• Wu J, Feng Y, Han C, et al. Germacrone derivatives: synthesis, biological activity, molecular docking studies and molecular dynamics simulations. Oncotarget. 2017;8(9):15149–15158.
   PubMed Web of Science ®Google Scholar
• Riaz A, Rasul A, Kanwal N, et al. Germacrone: a Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections. Curr Drug Metab. 2020;21(14):1079–1090.
   PubMed Web of Science ®Google Scholar
• Ye T, Zhang N, and Wu WY, et al. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis. Vitro Cell. Dev. Biol.-Anim. 2019;55(10):812–820.
   Google Scholar
• Mahmoudi T, Lorigooini Z, Rafieian-Kopaei M, et al. Effect of Curcuma zedoaria hydro-alcoholic extract on learning, memory deficits and oxidative damage of brain tissue following seizures induced by pentylenetetrazole in rat. Behav Brain Funct. 2020;16(1):7.
   PubMed Web of Science ®Google Scholar
• Zhuang S, Liu B, and Guo S, et al. Germacrone alleviates neurological deficits following traumatic brain injury by modulating neuroinflammation and oxidative stress. BMC Complement Med Ther. 2021;21(1):6.
   PubMedGoogle Scholar
• Zhang J, Yuan L, Wang S, et al. Germacrone protects against oxygen-glucose deprivation/reperfusion injury by inhibiting autophagy processes in PC12 cells. BMC Compl Med Ther. 2020;20(1):77.
   PubMedGoogle Scholar
• Kumaran A, Ho CC, Hwang LS. Protective effect of Nelumbo nucifera extracts on beta amyloid protein induced apoptosis in PC12 cells, in vitro model of Alzheimer’s disease. J Food Drug Anal. 2018;26(1):172–181.
   PubMed Web of Science ®Google Scholar
• Zhang J, An S, and Hu W, et al. The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer’s Disease Mouse Model. Int J Mol Sci. 2016;17:1810.
   PubMed Web of Science ®Google Scholar
• Tang L, Xiang Q, Xiang J, et al. Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Abeta25-35-induced Alzheimer’s disease by inhibiting the phosphorylation of IkappaBalpha and p38. Bioengineered. 2021;12(1):8540–8554.
   PubMed Web of Science ®Google Scholar
• Kruse AC, Kobilka BK, Gautam D, et al. Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat Rev Drug Discov. 2014;13(7):549–560.
   PubMed Web of Science ®Google Scholar
• Bock A, Schrage R, Mohr K. Allosteric modulators targeting CNS muscarinic receptors. Neuropharmacology. 2018;136:427–437.
   PubMed Web of Science ®Google Scholar
• Yin -Q-Q, Xu L-H, Zhang M, et al. Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling. Asian J Androl. 2018;20(6):608–614.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li M, Liu L, et al. Muscarinic M1 and M2 receptor subtypes play opposite roles in LPS-induced septic shock. Pharmacol Rep. 2019;71(6):1108–1114.
   PubMed Web of Science ®Google Scholar
• Fisher A. Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease. J Neurochem. 2012;120 Suppl 1(s1):22–33.
   PubMedGoogle Scholar
• Jiang S, Li Y, Zhang C, et al. M1 muscarinic acetylcholine receptor in Alzheimer’s disease. Neurosci Bull. 2014;30(2):295–307.
   PubMed Web of Science ®Google Scholar
• Khalid A, Shakeel R, Justin S, et al. Pharmacological Effects of Turmeric on Learning, Memory and Expression of Muscarinic Receptor Genes (M1, M3 and M5) in Stress-induced Mouse Model. Curr Drug Targets. 2017;18(13):1545–1557.
   PubMed Web of Science ®Google Scholar
• Chen MW, Zhu H, Xiong CH, et al. PKC and Ras are Involved in M1 Muscarinic Receptor-Mediated Modulation of AMPA Receptor GluA1 Subunit. Cell Mol Neurobiol. 2020;40(4):547–554.
   PubMed Web of Science ®Google Scholar
• Fisher A, Pittel Z, Haring R, et al. M1 Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer’s Disease: implications in Future Therapy. J Mol Neurosci. 2003;20(3):349–356.
   PubMed Web of Science ®Google Scholar
• Ma K, Yang ZH, Yang LM, et al. Activation of M1 mAChRs by lesatropane rescues glutamate neurotoxicity in PC12 cells via PKC-mediated phosphorylation of ERK1/2. Bosn J Basic Med Sci. 2013;13(3):146–152.
   PubMed Web of Science ®Google Scholar
• Huang L, Lin M, Zhong X, et al. Galangin decreases p‑tau, Aβ42 and β‑secretase levels, and suppresses autophagy in okadaic acid‑induced PC12 cells via an Akt/GSK3β/mTOR signaling‑dependent mechanism. Mol Med Rep. 2019;19(3):1767–1774.
   PubMed Web of Science ®Google Scholar
• Grace MS, Lieu T, Darby B, et al. The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo. Br J Pharmacol. 2014;171(16):3881–3894.
   PubMed Web of Science ®Google Scholar
• Yuan W, Guo J, Li X, et al. Hydrogen peroxide induces the activation of the phospholipase C-gamma1 survival pathway in PC12 cells: protective role in apoptosis. Acta Biochim Biophys Sin (Shanghai). 2009;41(8):625–630.
   PubMed Web of Science ®Google Scholar
• Cui Z, Tao T, Cheng C, et al. SSeCKS promote beta-amyloid-induced PC12 cells neurotoxicity by up-regulating tau phosphorylation in Alzheimer’s disease. Mol Cell Biochem. 2010;340(1–2):257–263.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego. Calif.). 2001;25:402–408.
   Google Scholar
• Marrocco I, Altieri F, Peluso I. Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans. Oxid Med Cell Longev. 2017;2017:6501046.
   PubMed Web of Science ®Google Scholar
• Olsson B, Lautner R, Andreasson U, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673–684.
   PubMed Web of Science ®Google Scholar
• Fu LL, Zhao XY, Ji LD, et al. Okadaic acid (OA): toxicity, detection and detoxification. Toxicon: Offl J Int Soc Toxinol. 2019;160:1–7.
   Google Scholar
• Kamat PK, Rai S, Nath C. Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer’s disease pathology. Neurotoxicology. 2013;37:163–172.
   PubMed Web of Science ®Google Scholar
• Koehler D, Williams FE. Utilizing zebrafish and okadaic acid to study Alzheimer’s disease. Neural Regen Res. 2018;13(9):1538–1541.
   PubMed Web of Science ®Google Scholar
• Kaushal A, Wani WY, Bal A, et al. Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer’s Type in Rats. Neurotox Res. 2019;35(3):621–634.
   PubMed Web of Science ®Google Scholar
• Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer’s disease. Pathol Int. 2017;67(4):185–193.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Arain HA, Stecker MM, et al. Amyloid toxicity in Alzheimer’s disease. Rev Neurosci. 2018;29:613–627.
   PubMed Web of Science ®Google Scholar
• Martin L, Latypova X, Wilson CM, et al. Tau protein kinases: involvement in Alzheimer’s disease. Ageing Res Rev. 2013;12(1):289–309.
   PubMed Web of Science ®Google Scholar
• Drummond E, Pires G, MacMurray C, et al. Phosphorylated tau interactome in the human Alzheimer’s disease brain. Brain. 2020;143(9):2803–2817.
   PubMedGoogle Scholar
• Yu CC, Jiang T, Yang AF, et al. Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease. Neural Plast. 2019;6856327. 10.1155/2019/6856327
   PubMed Web of Science ®Google Scholar
• Kamat PK, Rai S, Swarnkar S, et al. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor. Neuroscience. 2013;238:97–113.
   PubMed Web of Science ®Google Scholar
• Sun J, Roy S. The physical approximation of APP and BACE-1: a key event in Alzheimer’s disease pathogenesis. Dev Neurobiol. 2018;78:340–347.
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20:68–80.
   PubMed Web of Science ®Google Scholar
• Baek J, Lee MG. Oxidative stress and antioxidant strategies in dermatology. Redox Rep. 2016;21(4):164–169.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhong C. Oxidative stress in Alzheimer’s disease. Neurosci Bull. 2014;30(2):271–281.
   PubMed Web of Science ®Google Scholar
• Pohanka M. Oxidative stress in Alzheimer's disease as a target for therapy. Bratisl Lek Listy. 2018;119(9):535–543.
   PubMed Web of Science ®Google Scholar
• Bułdak RJ, Bułdak Ł, and Kukla M, et al., Significance of selected antioxidant enzymes in cancer cell progression. Polish journal of pathology. 2014;65:167–175.
   PubMed Web of Science ®Google Scholar
• Mathachan SR, Khurana A, Gautam RK, et al. Does oxidative stress correlate with disease activity and severity in vitiligo? An analytical study. J Cosmet Dermatol. 2021;20(1):352–359.
   PubMed Web of Science ®Google Scholar
• Wu T, Yin F, Kong H, et al. Germacrone attenuates cerebral ischemia/reperfusion injury in rats via antioxidative and antiapoptotic mechanisms. J Cell Biochem. 2019;120(11):18901–18909.
   PubMed Web of Science ®Google Scholar
• Yi JH, Whitcomb DJ, Park SJ, et al. M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer’s disease pathology. Brain Comm. 2020;2(2):fcaa058.
   PubMedGoogle Scholar